Global merger and acquisition activity continues to reshape industries ranging from container shipping and defence technology to pharmaceuticals and professional sports.
Five major announced transactions this past week have a combined disclosed value of more than $15 billion. The deals demonstrate how companies are using acquisitions, minority investments and strategic financing arrangements to expand capabilities, strengthen market positions and gain access to valuable intellectual property.
Below are the top five M&A deals announced in the week ending July 07, 2026. The data is curated from the Intellizence mergers & acquisitions Dataset.
| Acquiring Company | Acquired Company | Deal Size |
|---|---|---|
| Hapag Lloyd | ZIM Integrated Shipping Services | $11.3 billion |
| Lockheed Martin | Ultra Maritime | $3.4 billion |
| Apollo | Bayer Contraceptives (Stake) | $3.4 billion |
| Rogers Communications | Maple Leaf Sports & Entertainment (MLSE) | $3.1 billion |
| Novartis | Myricx Bio | $1.5 billion |
Hapag-Lloyd to merge with ZIM Integrated Shipping Services
Germany-based Hapag-Lloyd announced a merger agreement with Israel-based ZIM Integrated Shipping Services, the world’s 10th largest container shipping line, for $4 billion.
The transaction will strengthen Hapag-Lloyd’s global container shipping network by adding ZIM’s vessels, customers and international trade routes.
The acquisition is another significant step towards consolidation in the global container shipping industry. Combining the two businesses could provide Hapag-Lloyd with greater scale, expanded route coverage and improved fleet utilisation while intensifying competition among the world’s largest shipping companies.
Lockheed Martin acquired Ultra Maritime for $3.45 billion
Lockheed Martin acquired Ultra Maritime, a global defense company specializing in advanced undersea warfare and anti-submarine warfare (ASW) capabilities for allied naval forces, for $3.45 billion. Ultra Maritime develops undersea warfare, anti-submarine warfare, sonar, and maritime defence technologies for the United States and allied naval forces.
The acquisition will expand Lockheed Martin’s capabilities in submarine detection, underwater sensing, acoustic systems and autonomous maritime defence. The acquisition provides Lockheed Martin with specialised technology and domain expertise in a strategically important defence market. It also positions the company to capture rising demand for anti-submarine warfare and next-generation undersea surveillance systems.
Apollo to buy a $3.4 billion stake in Bayer Contraceptives business
Apollo will receive a minority, non-controlling interest, while Bayer will retain majority ownership and complete operational control. The business includes established long-acting contraceptive products and will remain part of Bayer’s core Pharmaceuticals operations.
The deal is expected to close during the third quarter of 2026, subject to antitrust approval and customary closing conditions. –Bayer transaction matters
Unlike a conventional acquisition, this transaction enables Bayer to raise substantial equity capital without surrendering control of the business. It demonstrates how alternative asset managers are increasingly using structured minority investments to provide capital to major corporations.
Rogers Communications has acquired the remaining 25% ownership stake in Maple Leaf Sports & Entertainment (MLSE)
Rogers Communications has acquired the remaining 25% ownership stake in Maple Leaf Sports & Entertainment (MLSE) from Kilmer Sports Inc. for C$4.35 billion (USD $3.1 billion). MLSE owns several prominent Canadian sports properties, including the Toronto Maple Leafs, Toronto Raptors, Toronto FC and Toronto Argonauts.
Full ownership of MLSE will allow Rogers to bring its professional sports franchises, media properties and distribution platforms under a more unified strategy. The transaction could create opportunities across broadcasting, streaming, sponsorships,
Novartis to acquire Myricx Bio for $1.5 billion.
Novartis to acquire Myricx Bio, a privately held UK-based biotechnology company, for $1.5 billion. Myricx is developing antibody-drug conjugates using a novel N-myristoyltransferase inhibitor payload platform. The transaction is expected to close during the second half of 2026, subject to regulatory approvals and customary closing requirements.
The acquisition strengthens Novartis’ oncology pipeline while giving it access to a differentiated antibody-drug conjugate platform.
Why Track the Latest M&A and Divestment Signals with Intellizence
Monitoring merger and acquisition announcements manually can be difficult, particularly when transactions involve multiple companies, currencies, regulatory stages and changing deal terms.
Intellizence provides structured M&A intelligence covering acquisitions, mergers, minority investments, asset sales, divestments, joint ventures and other corporate transactions.
With Intellizence, corporate development, investment, strategy, sales and research teams can:
- Discover newly announced M&A deals across industries and geographies.
- Filter transactions by company, industry, location, deal value, currency, transaction type and deal status.
- Track announced, completed, terminated, approved and speculative transactions.
- Monitor acquisition activity involving target accounts, competitors or portfolio companies.
- Access structured M&A data through the Intellizence web application, API and MCP connectors.
- Receive relevant company signals through saved searches and email alerts.
- Use M&A signals to identify integration, technology, advisory, hiring and supplier opportunities.
Frequently Asked Questions
What is an M&A dataset?
An M&A dataset is a structured database of mergers, acquisitions, divestments, stake purchases, asset sales, and related corporate transactions. It typically includes data points such as announcement date, acquirer, target company, seller, deal value, deal status, deal type, industry, geography, and source information.
Why do companies pursue mergers and acquisitions?
Companies pursue M&A to enter new markets, acquire technology, expand product portfolios, gain customers, increase operational scale, reduce competition, or improve their strategic position. The specific rationale depends on the buyer’s industry and long-term objectives.
Why are M&A deals important business signals?
M&A deals indicate major corporate change. They can signal growth, market expansion, product strategy, consolidation, restructuring, capital allocation priorities, and competitive repositioning. For sales, investment, strategy, and risk teams, M&A activity can create timely opportunities for outreach, analysis, and decision-making.
How can businesses track new M&A deals?
Businesses can use an M&A intelligence platform such as Intellizence to monitor transaction announcements, filter deals by relevant criteria, and receive alerts involving specific companies or industries. Structured M&A data can also be integrated into internal applications, CRM platforms, and AI workflows through APIs and MCP connectors.
How can I start using Intellizence M&A data?
You can start by exploring Intellizence M&A intelligence through the Web App or API, depending on your workflow and data requirements. Start your free trial.
Want to keep track of the largest Mergers & Acquisitions (M&A) deals in 2026? Check out the Largest Mergers and Acquisitions (M&A) Deals Data to stay informed about the latest M&A Deals.

Refreshed Daily